30 /100
MEDIUM RISK
Score updated Jul 14, 2026

WVE — Wave Life Sciences Ltd. Dilution Risk Tracker

Track WVE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track WVE — Get alerts when the score changes →

As of July 14, 2026, Wave Life Sciences Ltd. (WVE) has a DilutionWatch DilutionScore of 30/100, rated MEDIUM dilution risk. Wave Life Sciences Ltd. has a market capitalization of $1.27B, 192.38M shares outstanding, 237 institutional holders tracked. Key dilution vectors include approximately 97 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for WVE.
🔔 Track WVE — Get forecast alerts →

💹 Market Data

Market Cap$1.27B
Shares Outstanding192.38M
Float90.11M
Cash$569.63M
Debt$15.71M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 1.8% shares (2026Q1 vs prior)
237 institutional holders · 185.49M shares
#1 RA CAPITAL MANAGEMENT, L.P. 26.98M shares
#2 GSK plc 18.25M shares
#3 BlackRock, Inc. 14.12M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest20.90M
Days to Cover5.7
% of Float23.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2015
3 FORM3 Apr 17, 2026
3 FORM3 Apr 17, 2026
4 INSIDER TRANSACTION Mar 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for WVE Shareholders

Wave Life Sciences Ltd. (WVE) has a DilutionScore of 30/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for WVE shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for WVE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for WVE alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track WVE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking WVE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for WVE
📊 WVE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 WVE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.